GSK1605786A
114643
Phase 3 small_molecule terminated
Quick answer
GSK1605786A for Crohn's Disease is a Phase 3 program (small_molecule) at GlaxoSmithKline with 2 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Crohn's Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated